Infection and Immunity, September 1999, p. 4935-4938, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Internal Medicine and Center
for Vaccine Development1 and School of
Public Health,
Received 10 March 1999/Returned for modification 12 May
1999/Accepted 15 June 1999
Immunoglobulin G (IgG) subclass antibody responses to pneumococcal
vaccines were determined for human subjects in four age groups. The
ratios of IgG1/IgG2 antibody concentrations declined with advancing age
for all five of the serotypes tested. Protein-conjugate vaccines
elicited enhanced IgG antibody responses over plain polysaccharide vaccines in infants but not in adult groups.
*
Corresponding author. Mailing address: Division of
Infectious Diseases and Immunology, Saint Louis University Health
Sciences Center, 3635 Vista Ave. at Grand Blvd., FDT-8N, P.O. Box
15250, St. Louis, MO 63110-0250. Phone: (314) 577-8648. Fax: (314)
771-3816. E-mail: lottenkr{at}slu.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|